View Post

Anixa Biosciences Breast Cancer Vaccine Technology Nearing FDA Submission

In Clinical Studies News by Barbara Jacoby

From: Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that its prophylactic breast cancer vaccine is making progress towards clinical trials. Anixa and Cleveland Clinic intend to file the Investigational New Drug (IND) Application with the US Food and Drug Administration by the end of the …